Excision of this p300-bound translocated enhancer with TALE nucleases silenced EVI1 expression and stalled cellular growth in the inv(3) AML cell line, further demonstrating the driver nature of this genetic aberration. The gene discussed is RUNX1; the disease is acute myeloid leukemia.